Ocugen (OCGN) Other Accumulated Expenses (2015 - 2020)
Ocugen's (OCGN) quarterly Other Accumulated Expenses came in at $9755.0 in Q4 2020, down 95.26% YoY from $205991.0 in Q1 2020, and down 95.1% on a QoQ basis from $199261.0 in Q3 2020.
Analysis
Ocugen (OCGN) Other Accumulated Expenses (2015 - 2020) Analysis & Trends
Ocugen (OCGN) has 6 years of Other Accumulated Expenses data on file, last reported at $9755.0 in Q4 2020.
- Quarterly Other Accumulated Expenses fell 95.26% year-over-year to $9755.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $9755.0 (down 95.26% YoY) and the FY2020 annual result came in at $9755.0, down 95.26% from the prior year.
- Other Accumulated Expenses slipped to $9755.0 in Q4 2020, from $199261.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $632000.0 in Q4 2017 to a low of $9755.0 in Q4 2020.
- A 5-year average of $271315.5 and a median of $205425.5 in 2019 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2017 — Other Accumulated Expenses grew 24.41% — and 2020, when it sank 95.26%.
- Tracing OCGN's Other Accumulated Expenses over 5 years: stood at $508000.0 in 2016, then gained by 24.41% to $632000.0 in 2017, then tumbled by 67.68% to $204242.0 in 2018, then increased by 0.86% to $205991.0 in 2019, then slumped by 95.26% to $9755.0 in 2020.
- The last three Other Accumulated Expenses figures came in at $9755.0 (Q4 2020), $199261.0 (Q3 2020), and $204860.0 (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 9,755.00 |
| Sep 30, 2020 | 199,261.00 |
| Jun 30, 2020 | 204,860.00 |
| Mar 31, 2020 | 206,415.00 |
| Dec 31, 2019 | 205,991.00 |
| Dec 31, 2018 | 204,242.00 |
| Dec 31, 2017 | 632,000.00 |
| Dec 31, 2016 | 508,000.00 |
| Dec 31, 2015 | 548,000.00 |